Bill

Bill > HF217


IA HF217

A bill for an act relating to prior authorization requirements for the treatment of cancer.


summary

Introduced
02/06/2025
In Committee
02/06/2025
Crossed Over
Passed
Dead

Introduced Session

91st General Assembly

Bill Summary

This bill relates to prior authorization requirements for the treatment of cancer. Under the bill, a utilization review organization or a health carrier shall not require prior authorization for health care services that are recommended by a covered person’s health care provider based on the national comprehensive cancer network protocols.

AI Summary

This bill modifies existing Iowa healthcare law by prohibiting utilization review organizations (companies that review medical treatments for insurance purposes) and health carriers (insurance providers) from requiring prior authorization for cancer treatments that are recommended by a healthcare provider and align with National Comprehensive Cancer Network (NCCN) protocols. Prior authorization is a process where patients must get approval from their insurance company before receiving certain medical treatments, which can cause delays in care. By removing this requirement for cancer treatments that meet established professional guidelines, the bill aims to expedite access to recommended cancer therapies and reduce administrative barriers that might impede timely medical intervention. The change would apply specifically to treatments endorsed by the NCCN, which is a widely respected organization that develops evidence-based guidelines for cancer care.

Committee Categories

Health and Social Services

Sponsors (8)

Last Action

Introduced, referred to Health and Human Services. H.J. 254. (on 02/06/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...